Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale

BACKGROUND: COVID-19 associated acute respiratory distress syndrome (CARDS) is a severe form of SARS CoV-2 infection and affects about 15–30% of hospitalized patients with a high mortality rate. Growing research and data suggest several available drugs with appropriate pharmacological effects to tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulia, Eka Prasetya Budi, Luke, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443914/
https://www.ncbi.nlm.nih.gov/pubmed/34529182
http://dx.doi.org/10.1186/s43044-021-00208-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443914/
https://www.ncbi.nlm.nih.gov/pubmed/34529182
http://dx.doi.org/10.1186/s43044-021-00208-y

Ejemplares similares